Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel J Machin

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
American Journal of Hematology|February 28, 2012
Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpuraSpero R Cataland, Flora Peyvandi, Pier M Mannucci, et al.
Blood Advances|January 4, 2018
Use of the complement inhibitor Coversin to treat HSCT-associated TMATimothy H J Goodship, Fernando Pinto, Wynn H Weston-Davies, et al.
The Lancet. Haematology|August 30, 2016
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trialHannah Cohen, Beverley J Hunt, Maria Efthymiou, et al.
British Journal of Haematology|July 21, 2005
Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemiaDavid C Rees, Achille Iolascon, Massimo Carella, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
American Journal of Hematology|February 28, 2012
Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpuraSpero R Cataland, Flora Peyvandi, Pier M Mannucci, et al.
Blood Advances|January 4, 2018
Use of the complement inhibitor Coversin to treat HSCT-associated TMATimothy H J Goodship, Fernando Pinto, Wynn H Weston-Davies, et al.
The Lancet. Haematology|August 30, 2016
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trialHannah Cohen, Beverley J Hunt, Maria Efthymiou, et al.
British Journal of Haematology|July 21, 2005
Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemiaDavid C Rees, Achille Iolascon, Massimo Carella, et al.
Pageof 6